Humanized L243 antibodies

Details for Australian Patent Application No. 2006218454 (hide)

Owner Immunomedics, Inc.

Inventors Hansen, Hans J.; Goldenberg, David M.; Chang, Chien-Hsing; Qu, Zhengxing

Agent Davies Collison Cave

Pub. Number AU-B-2006218454

PCT Pub. Number WO2006/094192

Priority 60/657,695 03.03.05 US

Filing date 3 March 2006

Wipo publication date 8 September 2006

Acceptance publication date 17 November 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094192 Priority application(s): WO2006/094192

2 December 2010 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Chang, Chen-Hsing to Chang, ChienHsing 2006266529 GE Healthcare Bio-Sciences AB The nature of the amendment is: Amend co-inventor name from Brannholm, Maria to Holm, Maria

17 November 2011 Application Accepted

  Published as AU-B-2006218454

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218455-Compositions and methods for topical application and transdermal delivery of an oligopeptide

2006218449-Phthalazine, azaand diazaphthalazine compounds and methods of use